Results 231 to 240 of about 165,267 (310)

Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial

Addiction, Volume 121, Issue 7, Page 1899-1906, July 2026.
Abstract Background and aims Mandated reduction of the nicotine content of cigarettes to reduce addictiveness to minimal levels has the potential to substantially reduce combusted cigarette use and promote public health. This paper examined the hypothesis that when people who smoke cigarettes are switched to very low nicotine content (VLNC) cigarettes ...
Neal L. Benowitz, Jiayi Hu, Xianghua Luo, F. Joseph McClernon, Jennifer Tidey, Andrew A. Strasser, Suzanne Colby, Eric C. Donny, Dorothy K. Hatsukami   +8 more
wiley   +1 more source

Overnight Motor Memory Consolidation in Adolescents: Effects of Change in Dim Light Melatonin Onset After Sleep Restriction. [PDF]

J Biol Rhythms
Stager L, Gredvig-Ardito C, Crowley S, Seifer R, Carskadon M, Saletin J.   +5 more
europepmc   +1 more source

Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community‐Recruited Study

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Gabapentin is widely prescribed off‐label to treat pain. However, there are concerns about the proliferation of medical and non‐medical use, and the potential increased risk of overdose death associated with concurrent opioid use.
Evelyne Marie Piret, Heather Palis, Alexis Crabtree, JinCheol Choi, Kora DeBeck, Kanna Hayashi, Michael R. Law, M.‐J. Milloy   +7 more
wiley   +1 more source

Chagas Heart Disease: Social Determinants and Delayed Diagnosis. [PDF]

JACC Case Rep
Ho K, Ding E, Ding HH, Burtt DM.
europepmc   +1 more source

Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain‐Related Outcomes Among People With Non‐Heroin Opioid Use Disorder: Secondary Analyses From a Pragmatic Canadian Multisite Trial

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction In addition to their use as opioid agonist therapy (OAT), methadone and buprenorphine/naloxone also have analgesic properties. However, there is limited information on the relative effectiveness of these medications for analgesia in the context of treatment for non‐heroin opioid use disorder (OUD).
Katie Lyman, JinCheol Choi, Didier Jutras‐Aswad, Bernard L. E. Foll, Sukhpreet Klaire, M. Eugenia Socias   +5 more
wiley   +1 more source

Perforated Duodenal Ulcer in the Immediate Postpartum Period: Diagnostic Pitfalls Following Caesarean Delivery. [PDF]

Cureus
De Guzman J, Mar J, Jacobs M.
europepmc   +1 more source

How to Design and Implement a Structured Curriculum in Health Professions Education: A Nine‐Step Framework Building on Kern's Approach

The Clinical Teacher, Volume 23, Issue 4, August 2026.
Émile Escourrou, Stéphane Oustric
wiley   +1 more source

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6324-6333, July 2026.
ABSTRACT Aims In a phase 2 trial, the efficacy and safety of the highly selective aldosterone synthase inhibitor vicadrostat, alone or with empagliflozin, were investigated in people with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). Materials and Methods Adults (n = 586) with CKD (estimated glomerular filtration rate [eGFR] 30 to
David Z. I. Cherney, Peter Rossing, Maria Eugenia Canziani, Maria Luiza Caramori, Ricardo Correa‐Rotter, Lisa Cronin, Christian Hugo, Bo Ji, Juliane Meyerhoff, Masaomi Nangaku, Arnold Silva, Dorothea Urbach, Shimoli V. Shah, Dick de Zeeuw, Katherine R. Tuttle   +14 more
wiley   +1 more source

Increased Prevalence of Advanced Adenomas in Younger Individuals Undergoing Early Screening Colonoscopy Due to a Family History. [PDF]

Gastro Hep Adv
Yun J, Hanes D, Tarlow B.
europepmc   +1 more source